Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 223

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study

Roehrborn, Claus G., McVary, Kevin T., Elion-Mboussa, Albert, Viktrup, Lars·2008·Journal of Urology
DOI 10.1016/j.juro.2008.06.079
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.juro.2008.06.079

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Wei, 2005, Urologic Diseases in America Project: benign prostatic hyperplasia, J Urol, 173, 1256, 10.1097/01.ju.0000155709.37840.fe · DOI
  2. Jacobsen, 1997, Natural history of prostatism: risk factors for acute urinary retention, J Urol, 158, 481, 10.1016/S0022-5347(01)64508-7 · DOI
  3. Sagnier, 1995, Impact of symptoms of prostatism on level of bother and quality of life of men in the French community, J Urol, 153, 669, 10.1016/S0022-5347(01)67681-X · DOI
  4. Norman, 1994, ‘Prostate-related symptoms’ in Canadian men 50 years of age or older: prevalence and relationships among symptoms, Br J Urol, 74, 542, 10.1111/j.1464-410X.1994.tb09181.x · DOI
  5. McConnell, 2003, The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia, N Engl J Med, 349, 2387, 10.1056/NEJMoa030656 · DOI
  6. McVary, 2004, The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence, Curr Urol Rep, 5, 251, 10.1007/s11934-004-0047-1 · DOI
  7. Uckert, 2001, Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate, J Urol, 166, 2484, 10.1016/S0022-5347(05)65621-2 · DOI
  8. Filippi, 2007, Characterization and functional role of androgen-dependent PDE5 activity in the bladder, Endocrinology, 148, 1019, 10.1210/en.2006-1079 · DOI
  9. Gacci, 2007, Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study, J Urol, 178, 2040, 10.1016/j.juro.2007.07.048 · DOI
  10. Azadzoi, 2003, Chronic ischemia increases prostatic smooth muscle contraction in the rabbit, J Urol, 170, 659, 10.1097/01.ju.0000064923.29954.7e · DOI
  11. Berger, 2005, Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction, BJU Int, 96, 1073, 10.1111/j.1464-410X.2005.05777.x · DOI
  12. Pinggera, 2008, Alpha-blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms, BJU Int, 101, 319, 10.1111/j.1464-410X.2007.07339.x · DOI
  13. Andersson, 2007, Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS, Neurourol Urodyn, 26, 928, 10.1002/nau.20485 · DOI
  14. Ehren, 1994, Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses, Urology, 44, 683, 10.1016/S0090-4295(94)80206-8 · DOI
  15. Yoshimura, 2001, Nitric oxide modulates Ca(2+) channels in dorsal root ganglion neurons innervating rat urinary bladder, J Neurophysiol, 86, 304, 10.1152/jn.2001.86.1.304 · DOI
  16. Persson, 1992, Nitric oxide and relaxation of pig lower urinary tract, Br J Pharmacol, 106, 416, 10.1111/j.1476-5381.1992.tb14349.x · DOI
  17. McVary, 2007, Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia, J Urol, 177, 1401, 10.1016/j.juro.2006.11.037 · DOI · Paper page
  18. Barry, 1995, Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?, J Urol, 154, 1770, 10.1016/S0022-5347(01)66780-6 · DOI
  19. Dunn, 2002, Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms, Drugs Aging, 19, 135, 10.2165/00002512-200219020-00004 · DOI
  20. McVary, 2007, Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial, J Urol, 177, 1071, 10.1016/j.juro.2006.10.055 · DOI
  21. Stief, 2008, A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia, Eur Urol, 53, 1236, 10.1016/j.eururo.2008.01.075 · DOI
  22. Porst, 2006, Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial, Eur Urol, 50, 351, 10.1016/j.eururo.2006.02.052 · DOI · Paper page
  23. Rajfer, 2007, Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US, Int J Impot Res, 19, 95, 10.1038/sj.ijir.3901496 · DOI

Cited by

See all 223

Metadata

Authors
Roehrborn, C. G., McVary, K. T., Elion-Mboussa, A., & Viktrup, L.
Affiliations
  • Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
  • Department of Urology, Northwestern University, Chicago, Illinois
  • Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana
Venue
Journal of Urology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2008-10
Volume
180
Issue
4
Pages
1228-1234
ISSN
  • 0022-5347
  • 1527-3792
DOI
10.1016/j.juro.2008.06.079
Cited by
223
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.